LC
REPL icon

Lindbrook Capital’s Replimune Group REPL Stock Holding History

Lindbrook Capital’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$18.7K Hold
1,917
– – ﹤0.01% 1385
2024
Q4 		$23.2K Hold
1,917
– – ﹤0.01% 1201
2024
Q3 		$21K Sell
1,917
-2,046
-52% -$20.8K ﹤0.01% 1273
2024
Q2 		$35.7K Buy
3,963
+3,862
+3,824% +$26.9K ﹤0.01% 937
2024
Q1 		$825 Sell
101
-211
-68% -$1.73K ﹤0.01% 2451
2023
Q4 		$2.63K Buy
+312
New +$3.62K ﹤0.01% 2167
2023
Q3 		– Sell
-77
Closed -$1.79K – 2800
2023
Q2 		$1.79K Buy
+77
New +$1.5K ﹤0.01% 2187
2021
Q3 		– Sell
-1,400
Closed -$54K – 1982
2021
Q2 		$54K Buy
1,400
+900
+180% +$30.8K 0.01% 453
2021
Q1 		$15K Buy
+500
New +$18.7K ﹤0.01% 856
2020
Q1 		– Sell
-1,000
Closed -$14K – 1832
2019
Q4 		$14K Buy
+1,000
New +$14.4K ﹤0.01% 837

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Lindbrook Capital's REPL Position: Q1 2025 in Review

Lindbrook Capital held its Replimune Group (REPL) position steady in Q1 2025 at 1,917 shares worth $18.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1385.

Lindbrook Capital first reported a position in REPL in Q4 2019 and has held it in 10 quarters since. The position peaked at $54K in Q2 2021. 167 funds tracked by Wall St. Rank hold REPL as of Q1 2025.

  • Lindbrook Capital held 1,917 shares of Replimune Group worth $18.7K as of Q1 2025.
  • Lindbrook Capital left its Replimune Group share count unchanged in Q1 2025.
  • Replimune Group made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1385 holding.
  • Lindbrook Capital first reported a position in Replimune Group in Q4 2019 and has held it in 10 quarters since.
  • Lindbrook Capital's Replimune Group position peaked at $54K in Q2 2021.
  • 167 funds tracked by Wall St. Rank held Replimune Group as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.